Share prices of world's major vaccine manufacturers surge

London

A SURGE in profits and plans for a Covid-19 vaccination booster in the coming months have precipitated a boom in the share prices of the world's major vaccine manufacturers.

Shares of BioNtech and its partner Pfizer, as well as other vaccine producers, had sagged in the first quarter of this year. But since then, BioNtech has soared by 365 per cent and Pfizer by 45 per cent. Shares of Johnson & Johnson are up by 31 per cent, AstraZeneca are higher by 25 per cent, and Moderna has seen a 22 per cent increase.